Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 533
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 351–400 of 1,280 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05673577	Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients	completed	Phase 2	41	Fudan UniversityOTHER	1	Apr 2, 2026	clinicaltrials
NCT05924256	A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing	active not recruiting	Phase 2	88	Fudan UniversityOTHER	1	Apr 2, 2026	clinicaltrials